Top Markets
#1 Velas Velas +367.72%
#2 Gravity Gravity +48.70%
#3 Galxe Galxe +41.28%
#4 Infinity Ground Infinity Ground +30.80%
#5 Wiki Cat Wiki Cat +26.84%
#6 Audiera Audiera +26.57%
#7 Fetch.ai Fetch.ai +26.24%
#8 Derive Derive +24.86%
#9 Aria.AI Aria.AI +20.75%
#10 Babylon Babylon +18.83%
Coin of the day
Velas Velas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$38.41
Marktkapitalisatie
$170.67B
Verandering (1 dag)
1.17%
Verandering (1 jaar)
-49.92%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Healthcare
Marktkapitalisatie
Omzet
meer
Winst
Koersgeschiedenis
P/E-verhouding
P/S-verhouding
P/B-verhouding
Operationele marge
WPA
Aandelsplitsingen
Dividenden
Dividendrendement
Uitstaande aandelen
EPS voor Novo Nordisk A/S (NVO)
EPS per December 2025 TTM: $3.62
Volgens de laatste financiële rapporten en de aandelenkoers van Novo Nordisk A/S is de huidige EPS van het bedrijf (TTM) $3.62. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Novo Nordisk A/S van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 327.45%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 1,091.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 165.83%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -17.66%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $38.32 958.83%
NL